State of Wisconsin Investment Board’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-154,435
Closed -$1.18M 2598
2026
Q1
$1.18M Buy
154,435
+67,936
+79% +$630K ﹤0.01% 1616
2025
Q4
$978K Buy
86,499
+72,833
+533% +$741K ﹤0.01% 1692
2025
Q3
$126K Buy
+13,666
New +$98.9K ﹤0.01% 2304
2023
Q3
Sell
-117,000
Closed -$386K 2543
2023
Q2
$386K Buy
117,000
+22,230
+23% +$65.3K ﹤0.01% 1908
2023
Q1
$270K Sell
94,770
-31,166
-25% -$279K ﹤0.01% 2143
2022
Q4
$917K Buy
125,936
+62,249
+98% +$406K ﹤0.01% 1536
2022
Q3
$515K Buy
63,687
+35,403
+125% +$253K ﹤0.01% 1968
2022
Q2
$139K Sell
28,284
-6,616
-19% -$64.7K ﹤0.01% 2579
2022
Q1
$825K Sell
34,900
-22,400
-39% -$317K ﹤0.01% 1680
2021
Q4
$1.01M Buy
57,300
+43,700
+321% +$866K ﹤0.01% 1448
2021
Q3
$384K Buy
+13,600
New +$258K ﹤0.01% 1760
2021
Q2
Sell
-19,900
Closed -$234K 2099
2021
Q1
$234K Hold
19,900
﹤0.01% 1979
2020
Q4
$233K Buy
19,900
+400
+2% +$4.52K ﹤0.01% 1930
2020
Q3
$155K Hold
19,500
﹤0.01% 1929
2020
Q2
$357K Hold
19,500
﹤0.01% 1520
2020
Q1
$233K Buy
+19,500
New +$312K ﹤0.01% 1552

Other funds holding FULC

State of Wisconsin Investment Board's FULC Position: Q2 2026 in Review

State of Wisconsin Investment Board sold out of Fulcrum Therapeutics (FULC) in Q2 2026, closing a stake of 154,435 shares — an estimated $1.18M sold.

State of Wisconsin Investment Board first reported a position in FULC in Q1 2020 and held it in 16 quarters. The position peaked at $1.18M in Q1 2026. 155 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • State of Wisconsin Investment Board reported no remaining Fulcrum Therapeutics position as of Q2 2026 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 154,435 Fulcrum Therapeutics shares in Q2 2026, an estimated $1.18M.
  • State of Wisconsin Investment Board first reported a position in Fulcrum Therapeutics in Q1 2020 and held it in 16 quarters.
  • State of Wisconsin Investment Board's Fulcrum Therapeutics position peaked at $1.18M in Q1 2026.
  • 155 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.